ALX Oncology Holdings Inc (ALXO)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Jaume Pons |
| Employees: | 40 |
| Web site: | alxoncology.com |
|
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
650-466-7125
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
ALX Oncology Holdings Inc. focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial. ALTA-002, a SIRPa TRAAC that offers ways to engage the innate and adaptive immune response to cancer.
Please log in first to see chart